We are live on ! Find out more
ZSAN

Zosano Pharma Corporation
ZSAN

Delisted

ZSAN was delisted on the 10th of June, 2022.

Back to rankings

32 hedge funds and large institutions have $28.5M invested in Zosano Pharma Corporation in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,685% more capital invested

Capital invested by funds: $1.59M → $28.5M (+$26.9M)

136% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 11

88% more funds holding

Funds holding: 17 → 32 (+15)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
32
Holders Change
+15
Holders Change %
+88.24%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
3
Reduced
2
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.56M
2
NC
Nexthera Capital
New York
+$6.69M
3
HM
HealthCor Management
New York
+$5.26M
4
IHM
Iguana Healthcare Management
New York
+$4.78M
5
MIM
Monashee Investment Management
Massachusetts
+$4.3M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$260K
2
Victory Capital Management
Victory Capital Management
Texas
-$134K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$97K
4
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
-$54K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$42K
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$5.04M +$9.56M +28,571 New
NC
2
Nexthera Capital
New York
$3.53M +$6.69M +20,000 New
HM
3
HealthCor Management
New York
$2.77M +$5.26M +15,714 New
IHM
4
Iguana Healthcare Management
New York
$2.52M +$4.78M +14,286 New
MIM
5
Monashee Investment Management
Massachusetts
$2.27M +$4.3M +12,857 New
CH
6
CVI Holdings
Delaware
$1.89M +$3.58M +10,703 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.87M +$3.08M +9,211 +651%
SM
8
Sabby Management
Florida
$1.18M +$2.23M +6,679 New
HRCM
9
Hawk Ridge Capital Management
California
$1.01M +$1.91M +5,714 New
SCM
10
Stonepine Capital Management
Oregon
$1.01M +$1.91M +5,714 New
TI
11
Telemetry Investments
New York
$697K +$1.32M +3,951 New
Millennium Management
12
Millennium Management
New York
$629K +$1.19M +3,565 New
GPCM
13
Granite Point Capital Management
Massachusetts
$504K +$884K +2,643 +1,235%
OM
14
Opaleye Management
Massachusetts
$504K +$956K +2,857 New
Verition Fund Management
15
Verition Fund Management
Connecticut
$504K +$956K +2,857 New
Squarepoint
16
Squarepoint
New York
$445K +$844K +2,524 New
TAM
17
Tiverton Asset Management
Delaware
$403K +$765K +2,286 New
LOAMU
18
Lombard Odier Asset Management (USA)
New York
$353K +$669K +2,000 New
BFM
19
Boothbay Fund Management
New York
$272K +$515K +1,541 New
FCM
20
Flinton Capital Management
Pennsylvania
$206K +$390K +1,166 New
TAM
21
Tyers Asset Management
Texas
$169K +$321K +960 New
Morgan Stanley
22
Morgan Stanley
New York
$139K +$170K +507 +179%
Bank of Montreal
23
Bank of Montreal
Ontario, Canada
$139K +$263K +786 New
NA
24
Neuburgh Advisers
California
$133K +$252K +754 New
MCIM
25
Meadow Creek Investment Management
Georgia
$97K +$184K +549 New
1
2

ZSAN Hedge Fund Activity: Q1 2018 in Review

32 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q1 2018, worth a combined $28.5M — up 1,685% from $1.59M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ZSAN positions and 11 closed out — a net gain of 15 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $9.56M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $260K sold.

  • 32 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q1 2018, up from 17 in Q4 2017.
  • Funds reported $28.5M of Zosano Pharma Corporation stock for Q1 2018, up 1,685% quarter-over-quarter.
  • 26 funds opened new Zosano Pharma Corporation positions in Q1 2018 and 11 closed out, a net change of +15 holders.
  • The largest Zosano Pharma Corporation buyer in Q1 2018 was Adage Capital Partners, an estimated $9.56M added.
  • The largest Zosano Pharma Corporation seller in Q1 2018 was Perceptive Advisors, an estimated $260K sold.

Based on aggregated 13F filings for Q1 2018.